The Cigna Group (CI)
Wake Up Wall Street - 2 Massively Mispriced Dividend Gems
I believe the odds favor long-term market gains. Analysts' optimism supports my view that overlooked areas offer the best opportunities now. That's why I'm focusing on two dividend stocks with rising income and resilience, one in energy, and one in healthcare, built for long-term success. Forget the headlines. Quality, time, and patience build wealth. I'm doubling down on proven businesses, no matter what short-term noise brings.
Here's Why You Should Hold Cigna Stock in Your Portfolio for Now
CI gains 14.7% YTD as Evernorth and Cigna Healthcare drive growth, but rising expenses and debt pose challenges.
CVS or Cigna: Which Diversified Healthcare Stock Should You Own Now?
CVS rallies on turnaround momentum and EPS growth, while CI is a defensive play with stable returns and a focused healthcare strategy.
Cigna announces new deal for copay caps on Eli Lilly and Novo Nordisk weight loss drugs
Cigna's Evernorth unit said a new coverage deal with Eli Lilly and Novo Nordisk will bring lower copays for insured patients The company hopes the new discount, which caps monthly out-of-pocket costs at $200 for Wegovy and Zepbound, will convince more employers to offer coverage of the drugs.
Cigna and CVS shares fall as Trump targets ‘middlemen' in sweeping executive order against Big Pharma
The market reaction came as Trump signed a wide-ranging executive order aimed at slashing prescription drug prices in the US.
Cigna Q1 Earnings Beat Estimates on Evernorth Health Strength
CI increases adjusted earnings guidance for 2025 to $29.60 per share from the previous estimate of $29.50.
Cigna (CI) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
While the top- and bottom-line numbers for Cigna (CI) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Cigna (CI) Q1 Earnings and Revenues Surpass Estimates
Cigna (CI) came out with quarterly earnings of $6.74 per share, beating the Zacks Consensus Estimate of $6.39 per share. This compares to earnings of $6.47 per share a year ago.
Cigna raises full-year profit forecast, latest to beat medical cost estimates
Cigna on Friday raised its full-year earnings forecast and beat estimates for quarterly profit, helped by strong performance in its pharmacy benefit management business and lower-than-expected medical costs in its insurance arm.
Will Declining Medical Customers Affect Cigna's Q1 Earnings?
CI's first-quarter results are likely to have benefited from growing pharmacy revenues and fees.
Curious about Cigna (CI) Q1 Performance? Explore Wall Street Estimates for Key Metrics
Besides Wall Street's top -and-bottom-line estimates for Cigna (CI), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2025.
Earnings Preview: Cigna (CI) Q1 Earnings Expected to Decline
Cigna (CI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
